Our Philadelphia valsartan drug injury lawyers are investigating cases involving injuries from the drug valsartan for possible future litigation. Note: We are not filing valsartan lawsuits at this time. If you have taken a valsartan medication and have developed liver, kidney, lung, or other cancer, please contact us to discuss the possibility of filing a valsartan lawsuit.
Multiple batches / lots of valsartan medications have been shown to contain a probable cancer-causing chemical, N-nitrosodimethylamine (NDMA). NDMA can lead to:
- liver damage
- liver cancer / tumors
- kidney cancer / tumors
- lung cancer / tumors
- other cancers and tumors
Valsartan was previously sold under the brand name Diovan, which is no longer on the market. Valsartan is currently sold as a generic medication to treat:
- high blood pressure / hypertension
- heart failure
- left ventricular failure
- left ventricular dysfunction related to heart attack / myocardial infarction
FDA Valsartan Recall
On July 13, 2018, the U.S. Food and Drug Administration (FDA) announced a recall of specified lots of valsartan and valsartan hydrochlorothiazide (HCTZ) medications sold in the United States due to the presence of N-nitrosodimethylamine (NDMA). The Environmental Protection Agency has classified NDMA as a probable human carcinogen, a substance that can increase the risk of cancer. According to the FDA, amounts of NDMA found in the recalled valsartan drugs exceed levels acceptable for human safety and pose an unnecessary risk of injury.
The active ingredient (valsartan) in the recalled products was manufactured by a company in Linhai, China, called Zhejiang Huahai Pharmaceuticals. The presence of NDMA in the recalled medications is suspected to have resulted from changes in which the active ingredient, valsartan, was manufactured.
The recalled products containing the tainted valsartan were sold in the United States by:
- Teva Pharmaceuticals USA (labeled as Major Pharmaceuticals)
- Prinston Pharmaceuticals, Inc. (labeled as Solco Healthcare LLC)
- Teva Pharmaceuticals (labeled as Actavis LLC)
On August 9, 2018, the FDA expanded its valsartan recall to include valsartan products sold by:
- A-S Medication Solutions LLC
- Bryant Ranch Prepack Inc.
- H J Harkins Company
- Northwind Pharmaceuticals
- Proficient Rx LP
- Remedy Repack
Not all valsartan drugs sold by these companies are included in the current recall. A detailed list of recalled valsartan-containing products is listed here. Valsartan drug products not included in the recall are listed here.
Lawsuits that may be brought by Philadelphia valsartan drug injury lawyers at a future time may allege that manufacturers and distributors of valsartan drugs / medications:
- produced, marketed, and distributed an unreasonably dangerous product
- negligently failed to conduct adequate testing of valsartan used to produce valsartan drugs
- caused serious injury and / or death to users of tainted valsartan medications
Contact our Philadelphia Valsartan Drug Injury Lawyers
If you or one of your family members has been diagnosed with liver damage or liver, kidney, lung, or other cancer after taking a valsartan medication, you may be entitled to compensation through legal action. Contact our Philadelphia valsartan drug injury lawyers, today, to receive a free evaluation of your case.
If we determine that you may have grounds for filing a valsartan lawsuit against manufacturers and distributors of NDMA-tainted valsartan medications, we will keep your information on file and contact you if we decide to pursue valsartan litigation.